These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 26268449)
1. Resistance-Mutation (N31) Effects on Drug Orientation and Channel Hydration in Amantadine-Bound Influenza A M2. Gleed ML; Ioannidis H; Kolocouris A; Busath DD J Phys Chem B; 2015 Sep; 119(35):11548-59. PubMed ID: 26268449 [TBL] [Abstract][Full Text] [Related]
2. Analysis by metadynamics simulation of binding pathway of influenza virus M2 channel blockers. Sakai Y; Kawaguchi A; Nagata K; Hirokawa T Microbiol Immunol; 2018 Jan; 62(1):34-43. PubMed ID: 29210473 [TBL] [Abstract][Full Text] [Related]
3. Why bound amantadine fails to inhibit proton conductance according to simulations of the drug-resistant influenza A M2 (S31N). Gleed ML; Busath DD J Phys Chem B; 2015 Jan; 119(3):1225-31. PubMed ID: 25426702 [TBL] [Abstract][Full Text] [Related]
4. A secondary gate as a mechanism for inhibition of the M2 proton channel by amantadine. Yi M; Cross TA; Zhou HX J Phys Chem B; 2008 Jul; 112(27):7977-9. PubMed ID: 18476738 [TBL] [Abstract][Full Text] [Related]
5. How does influenza virus a escape from amantadine? Qin G; Yu K; Shi T; Luo C; Li G; Zhu W; Jiang H J Phys Chem B; 2010 Jul; 114(25):8487-93. PubMed ID: 20521806 [TBL] [Abstract][Full Text] [Related]
6. Structure and inhibition of the drug-resistant S31N mutant of the M2 ion channel of influenza A virus. Wang J; Wu Y; Ma C; Fiorin G; Wang J; Pinto LH; Lamb RA; Klein ML; Degrado WF Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1315-20. PubMed ID: 23302696 [TBL] [Abstract][Full Text] [Related]
7. Structural comparison of the wild-type and drug-resistant mutants of the influenza A M2 proton channel by molecular dynamics simulations. Gu RX; Liu LA; Wang YH; Xu Q; Wei DQ J Phys Chem B; 2013 May; 117(20):6042-51. PubMed ID: 23594107 [TBL] [Abstract][Full Text] [Related]
8. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers. Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183 [TBL] [Abstract][Full Text] [Related]
9. Why amantadine loses its function in influenza m2 mutants: MD simulations. Laohpongspaisan C; Rungrotmongkol T; Intharathep P; Malaisree M; Decha P; Aruksakunwong O; Sompornpisut P; Hannongbua S J Chem Inf Model; 2009 Apr; 49(4):847-52. PubMed ID: 19281265 [TBL] [Abstract][Full Text] [Related]
10. Drug-induced conformational and dynamical changes of the S31N mutant of the influenza M2 proton channel investigated by solid-state NMR. Williams JK; Tietze D; Wang J; Wu Y; DeGrado WF; Hong M J Am Chem Soc; 2013 Jul; 135(26):9885-97. PubMed ID: 23758317 [TBL] [Abstract][Full Text] [Related]
11. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Cady SD; Schmidt-Rohr K; Wang J; Soto CS; Degrado WF; Hong M Nature; 2010 Feb; 463(7281):689-92. PubMed ID: 20130653 [TBL] [Abstract][Full Text] [Related]
12. How amantadine and rimantadine inhibit proton transport in the M2 protein channel. Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883 [TBL] [Abstract][Full Text] [Related]
13. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus. Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753 [TBL] [Abstract][Full Text] [Related]
14. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313 [TBL] [Abstract][Full Text] [Related]
15. Membrane-dependent effects of a cytoplasmic helix on the structure and drug binding of the influenza virus M2 protein. Cady S; Wang T; Hong M J Am Chem Soc; 2011 Aug; 133(30):11572-9. PubMed ID: 21661724 [TBL] [Abstract][Full Text] [Related]
16. Binding hot spots and amantadine orientation in the influenza a virus M2 proton channel. Chuang GY; Kozakov D; Brenke R; Beglov D; Guarnieri F; Vajda S Biophys J; 2009 Nov; 97(10):2846-53. PubMed ID: 19917240 [TBL] [Abstract][Full Text] [Related]
17. Structure and mechanism of the M2 proton channel of influenza A virus. Schnell JR; Chou JJ Nature; 2008 Jan; 451(7178):591-5. PubMed ID: 18235503 [TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the drug-resistant S31N influenza M2 proton channel. Thomaston JL; DeGrado WF Protein Sci; 2016 Aug; 25(8):1551-4. PubMed ID: 27082171 [TBL] [Abstract][Full Text] [Related]
19. The chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain. Hu J; Fu R; Cross TA Biophys J; 2007 Jul; 93(1):276-83. PubMed ID: 17434944 [TBL] [Abstract][Full Text] [Related]
20. X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance. Thomaston JL; Konstantinidi A; Liu L; Lambrinidis G; Tan J; Caffrey M; Wang J; Degrado WF; Kolocouris A Biochemistry; 2020 Feb; 59(4):627-634. PubMed ID: 31894969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]